HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jan van der Meer Selected Research

Protein S Deficiency (Deficiency, Protein S)

5/2009Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives.
1/2009High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin.
7/2008Relationship between progression to AIDS and thrombophilic abnormalities in HIV infection.
7/2007High risk of pregnancy-related venous thromboembolism in women with multiple thrombophilic defects.
3/2005Protein S type III deficiency is no risk factor for venous and arterial thromboembolism in 168 thrombophilic families: a retrospective study.
7/2002Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jan van der Meer Research Topics

Disease

12Venous Thromboembolism
01/2009 - 03/2002
8Venous Thrombosis (Deep-Vein Thrombosis)
04/2010 - 07/2002
6Protein S Deficiency (Deficiency, Protein S)
05/2009 - 07/2002
6Hyperhomocysteinemia
01/2009 - 10/2004
6Protein C Deficiency
01/2009 - 07/2002
6Thrombosis (Thrombus)
07/2008 - 03/2005
4Hemorrhage
05/2009 - 08/2005
4Atherosclerosis
05/2009 - 10/2006
4Thromboembolism
10/2008 - 07/2004
3Cardiovascular Diseases (Cardiovascular Disease)
11/2010 - 10/2006
3Activated Protein C Resistance (APC Resistance)
07/2007 - 07/2002
2Thrombophilia
04/2010 - 05/2009
2Wounds and Injuries (Trauma)
01/2008 - 12/2006
1Menorrhagia
10/2010
1Fetal Death
08/2010
1Neoplasms (Cancer)
05/2009
1Acquired Immunodeficiency Syndrome (AIDS)
07/2008
1Myocardial Infarction
02/2008
1Proteinuria
01/2008
1Cytomegalovirus Infections (Inclusion Disease)
01/2008
1Hemophilia A (Haemophilia)
01/2008
1Inborn Genetic Diseases (Disease, Hereditary)
08/2006
1Testicular Neoplasms (Testicular Cancer)
12/2005
1Liver Diseases (Liver Disease)
08/2005
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
07/2004
1Infections
07/2002

Drug/Important Bio-Agent (IBA)

13Protein SIBA
08/2010 - 07/2004
10Protein CIBA
08/2010 - 07/2002
8AntithrombinsIBA
08/2010 - 07/2002
8Prothrombin (Factor II)IBA
04/2010 - 07/2002
8Factor VIII (Coagulation Factor VIII)IBA
07/2008 - 10/2002
6factor V LeidenIBA
04/2010 - 03/2002
6AnticoagulantsIBA
05/2009 - 03/2002
4Oral ContraceptivesIBA
05/2009 - 07/2002
2omega-Chloroacetophenone (Mace)IBA
11/2010 - 02/2008
2von Willebrand FactorIBA
08/2010 - 12/2005
2Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA
07/2008 - 10/2002
2HomocysteineIBA
08/2007 - 10/2004
1Dihydrotachysterol (AT 10)IBA
05/2009
1Fibrinogen (Factor I)FDA Link
07/2008
1Serum AlbuminIBA
01/2008
1sugar formulated recombinant FVIIIIBA
01/2008
1Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
07/2007
1Combined Oral ContraceptivesIBA
02/2007
1AntigensIBA
08/2006
1Hemostatics (Antihemorrhagics)IBA
12/2005
1Bleomycin (Blenoxane)FDA LinkGeneric
12/2005
1Cisplatin (Platino)FDA LinkGeneric
12/2005
1recombinant FVIIa (rFVIIa)FDA Link
08/2005
1Vitamin KFDA Link
12/2004
1Antiphospholipid AntibodiesIBA
07/2004
1Lipoprotein(a)IBA
10/2002
1Factor XI (Plasma Thromboplastin Antecedent)IBA
10/2002
1Proteins (Proteins, Gene)FDA Link
10/2002
1ThrombinFDA Link
07/2002

Therapy/Procedure

2Therapeutics
10/2010 - 12/2004
2Liver Transplantation
08/2005 - 07/2002
1Hysterectomy
10/2010
1Ligation
07/2008
1Kidney Transplantation
01/2008
1Drug Therapy (Chemotherapy)
12/2005
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
07/2002